TY - JOUR
T1 - Stem cell origins of JMML
AU - Sundaravel, Sriram
AU - Steidl, Ulrich
N1 - Funding Information:
S. Sundaravel is supported by the National Cancer Institute (K00CA223044) and the Harry Eagle Scholar award.
Publisher Copyright:
© 2021 Sundaravel and Steidl.
PY - 2021
Y1 - 2021
N2 - In this issue of JEM, Louka et al. (https://doi.org/10.1084/jem.20180853) report that leukemia stem cells lie within the phenotypic hematopoietic stem cell and progenitor cell compartments in juvenile myelomonocytic leukemia (JMML). Furthermore, they identify several candidate biomarker/therapeutic targets, such as CD96 and SLC2A1, that are of translational significance in JMML.
AB - In this issue of JEM, Louka et al. (https://doi.org/10.1084/jem.20180853) report that leukemia stem cells lie within the phenotypic hematopoietic stem cell and progenitor cell compartments in juvenile myelomonocytic leukemia (JMML). Furthermore, they identify several candidate biomarker/therapeutic targets, such as CD96 and SLC2A1, that are of translational significance in JMML.
UR - http://www.scopus.com/inward/record.url?scp=85100070488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100070488&partnerID=8YFLogxK
U2 - 10.1084/JEM.20202152
DO - 10.1084/JEM.20202152
M3 - Article
C2 - 33427877
AN - SCOPUS:85100070488
SN - 0022-1007
VL - 218
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 2
M1 - e20202152
ER -